Top 100 Biotech & Life Science Investors Worldwide – Venture Capital, Family Offices, Private Equity

299,99

  • Top 100 Biotech Investors Worldwide
  • Useful information like investment focus, investments, contact persons and contact details
  • Download forever valid
  • Last update: September 13, 2017

Customers who bought this item also bought:
Top 100 Private Equity Funds Germany
Top 100 Single Family Offices in America

Description

We offer an overview of the world’s 100 most relevant Biotech and Life Science investors. Our list includes venture capital fonds, corporate venture capital funds,  family offices and private investors. The listed investors are based in America as well as in Europe. You can get in touch with them through their website, email or phone. In many cases, also contact persons (for example managing directors) and their email or phone address are included.

  • Name
  • Investor Type (Venture Capital / Family Office / etc.)
  • Focus
  • Latest relevant Investments
  • Country
  • URL
  • E-Mail Generic
  • General Phone Number
  • Contact Person (Name, Position) – if possible
  • Contact Person Phone Number – if possible
  • Contact Person E-Mail – if possible

3 Good Reasons to buy our Venture Capital list

There are many benefits from buying our l list:

  • You will save tons of time of exhausting research. Our list offers detailed information about the most important Biotech investors
  • You will be able to directly speak to the VCs through E-Mail, Post, Phone or LinkedIn.
  • We will help you with any requests

In case of any questions, or if you want to receive a Top 10 preview file, feel free to send an email to contact [at] researchgermany.com or to use our live-chat. We will even assist you to establish contact with German companies or create custom-tailored lists for you.

Largest Life Science Investors Venture Capital Family Offices

Reviews

There are no reviews yet.

Be the first to review “Top 100 Biotech & Life Science Investors Worldwide – Venture Capital, Family Offices, Private Equity”

Your email address will not be published. Required fields are marked *